Should patients with minor strokes be given thrombolytics?
Mild stroke symptoms are cited as the reason for not using tissue-type plasminogen activator in 29–43% of time-eligible patients. Previous studies suggested that not all of these patients had a good recovery or even survival to hospital discharge. Since then, stroke guidelines worldwide recommended...
Saved in:
| Main Authors: | Yi Dong, Qiang Dong, David Wang, Xun Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
|
| Series: | Stroke and Vascular Neurology |
| Online Access: | https://svn.bmj.com/content/early/2024/08/01/svn-2024-003451.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A nomogram for predicting early thrombolytic efficacy in stroke patients
by: Chen Lou, et al.
Published: (2025-08-01) -
Endovascular and Thrombolytic Therapy and the Functional Status of Patients after Ischemic Stroke
by: Renata Jabłońska, et al.
Published: (2019-06-01) -
Assessment of the Functional Status of Patients with Ischaemic Stroke Receiving Thrombolytic Treatment
by: Kazimiera Hebel, et al.
Published: (2020-06-01) -
Systemic Thrombolytic Therapy for Ischemic Stroke in the Course of Anticoagulants
by: L. Kh.-B. Akhmatkhanova, et al.
Published: (2021-11-01) -
The glucose-to-potassium ratio: a predictor of poor functional outcomes in stroke patients receiving thrombolytic therapy
by: Dong Zhang, et al.
Published: (2025-06-01)